NEW YORK, Jan. 26 (GenomeWeb News) - Health Discovery said today that it has signed an agreement acquiring the first option to obtain the exclusive worldwide rights to commercialize prostate cancer biomarkers or pathways identified by the company as part of a collaboration with the University of Texas, MD Anderson Cancer Center.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.